DIN 02529025 — APO-DEXLANSOPRAZOLE 60 MG
APO-DEXLANSOPRAZOLE is a capsule (delayed-release) of Dexlansoprazole marketed by APOTEX INC. The full Dexlansoprazole monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02529025
- Brand name
- APO-DEXLANSOPRAZOLE
- Active ingredient
- Dexlansoprazole
- Strength
- 60 MG
- Dosage form
- CAPSULE (DELAYED-RELEASE)
- Route
- NASOGASTRIC; ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Proton pump inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Dexlansoprazole products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02528991 | APO-DEXLANSOPRAZOLE | 30 MG | CAPSULE (DELAYED-RELEASE) | APOTEX INC | MARKETED |
| 02354950 | DEXILANT | 30 MG | CAPSULE (DELAYED-RELEASE) | TAKEDA CANADA INC | MARKETED |
| 02354969 | DEXILANT | 60 MG | CAPSULE (DELAYED-RELEASE) | TAKEDA CANADA INC | MARKETED |